Introducing Apollo, the automated, high sensitivity, protein structural characterisation tool
06 May, 2022 | Newsletters
|Apollo provides ultra-sensitive, ultra-precise measurements of the structure of biomolecules through a novel technology called Microfluidic Modulation Spectroscopy (MMS), now even more rapidly, with less sample volume, and with improved software and analytics features.
MMS overcomes many of the limitations of existing technologies in a typical biophysical characterisation toolkit with ultra-sensitive and highly reproducible structural measurements of proteins and other biomolecules. Users are able to compare higher-order structure and similarity profiles for confidence in structural similarity and activity to inform discovery, screening, formulation, and quality control in biopharmaceutical drug development. It can be used for a wide range of biomolecules from mAb-based biotherapeutics to robust measurements of ADCs, AAVs, and mRNA.
Key features and benefits of Apollo include: Accurate and reproducible measurements with broad concentration range from 0.1 mg/ml to >200 mg/ml allows measurements in native conditions 20x faster and 30x more sensitive to changes in structure than CD or FTIR Real-time buffer subtraction minimises background noise and interference from excipients Dramatically reduced sample volume requirements
READ MORE HERE
Get your brochure – click here
Learn more about Apollo and the benefits of adding MMS into your biophysical characterisation toolkit.
30 Minute Webinar: Register here
Webinar will present the features and benefits of Apollo, May 24 2022
Register for webinar- click here
In this webinar, learn how this fully-automated IR technology, generates high-quality, reproducible secondary structure data for protein therapeutics, including monoclonal antibodies. June,10 2022
|Request a personal demo Request a quote now Email us for more info